LABIOTECH.eu: Biotech’s crowdfunding: is France top of the class?

/in , /by

Biotech’s crowdfunding: is France top of the class?
By Joachim Eeckhout – Published on December 22, 2014 | LABIOTECH.eu

“In France, you can feel a real enthusiasm for crowdfunding and many projects are running on different platforms. I met several companies currently fundraising to understand their reasons and issues. The first of these, Acticor Biotech, develops an antibody inhibitor of arterial thrombosis, directed against the glycoprotein 6 (GP6), a new therapeutic target on the surface of platelets.[…]”

Full article in English : http://labiotech.eu/biotechs-crowdfunding-france-top-class/